sglt2 inhibitors vs glp-1 agonists Combining Receptor and in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique SGLT2 Inhibitors vs. GLP-1 Agonists

sglt2 inhibitors vs glp-1 agonists

sglt2 inhibitors vs glp-1 agonists Combining Receptor and in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique SGLT2 Inhibitors vs. GLP-1 Agonists

Name: sglt2 inhibitors vs glp-1 agonists Combining Receptor and in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique SGLT2 Inhibitors vs. GLP-1 Agonists
Brand: wefit.es
SKU: 17727858747
Price: 29.08 USD
Availability: InStock
Rating: 4.7731 (18 reviews)

SKU: 17727858747

4.8

EUR29.08 EUR57.08

Pay in 4 interest-free payments of $7.27 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 18 - Aug 23

Description

Phase Ia/b Study of Giredestrant +/- Palbociclib and +/- luteinizing hormone-releasing hormone agonists in estrogen receptor-positive, HER2-Negative, locally advanced/metastatic breast cancer